|UFDC Home||| Help ||
CITATION PDF VIEWER
STANDARD VIEW MARC VIEW
RESEARCHOpenAccessParticipationandqualityoflifeinchildrenwith Duchennemusculardystrophyusingthe InternationalClassificationofFunctioning, Disability,andHealthRoxannaMBendixen1*,ClaudiaSenesac2,DonovanJLott3andKristaVandenborne4AbstractBackground: Duchennemusculardystrophy(DMD)ischaracterizedbymuscledamageandprogressivelossof musclefunctioninmalechildren.DMDisoneofthemostdevastatinggeneticallylinkedneuromusculardiseasesfor whichthereiscurrentlynocure.MostclinicalstudiesforDMDutilizeastandardprotocolformeasurement exploringpathophysiology,musclestrengthandtimedtasks.However,weproposethatexaminingbroader componentsofhealthasemphasizedbytheInternationalClassificationofFunctioning,DisabilityandHealthChildrenandYouthVersion(ICF-CY)maybeofgreatvaluetochildrenandtheirfamilies,andimportantoutcomes forfutureclinicaltrials. Methods: FiftyboyswithDMDand25unaffectedage-matchedboyscompletedtwoself-reportmeasures:the Children sAssessmentofParticipationandEnjoymentandthePediatricQualityofLifeInventoryTM4.0.We investigateddifferencesbetweenthetwogroupswithregardtoparticipationinlifeactivitiesandperceivedquality oflife(QoL).Additionally,wecomparedparticipationinactivitiesandQoLinbothcohortsofyoungerandolder boys. Results: ParticipationinphysicalactivitieswassignificantlylowerinboyswithDMDthanunaffectedboys.Perceived QoLwasmarkedlydiminishedinchildrenwithDMDrelativetounaffectedcontrols,exceptintheemotional domain.Theamountoftimeboysengageinanactivity,aswellasparticipationinsocialactivities,declinedforour olderboyswithDMDbutnochangeswereobservedforourolderunaffectedboys.Forbothgroups,QoLremained constantovertime. Conclusions: TheICF-CYprovidesaconceptualframeworkandspecificterminologythatfacilitatesinvestigationof theconsequencesofimpairmentinchildrenandyouth.Ourstudyisoneofthefirsttoexploreparticipationina cohortofboyswithDMD.ItwasnotsurprisingthatactivitiesofchoiceforboyswithDMDwerelessphysicalin naturethanunaffectedboystheirage,buttheconsequencesoflesssocialengagementastheboyswithDMDage isofgreatconcern.Resultsfromourstudyunderscoretheneedtofurtherevaluateactivitiesthatchildrenelectto participatein,withspecialemphasisonfacilitatorsandbarrierstoparticipationandhowparticipationchanges throughoutthecourseofadisease. Keywords: Duchennemusculardystrophy,ICF,Participation,Qualityoflife *Correspondence: firstname.lastname@example.orgDepartmentofOccupationalTherapy,UniversityofFlorida,Gainesville, FL32611,USA Fulllistofauthorinformationisavailableattheendofthearticle 2012Bendixenetal.;licenseeBioMedCentralLtd.ThisisanOpenAccessarticledistributedunderthetermsoftheCreative CommonsAttributionLicense(http://creativecommons.org/licenses/by/2.0),whichpermitsunrestricteduse,distribution,and reproductioninanymedium,providedtheoriginalworkisproperlycited.Bendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43 http://www.hqlo.com/content/10/1/43
BackgroundDuchennemusculardystrophy(DMD),themostcommon formofmusculardystrophy,isagenetically-linkeddisease ofmalechildrenwhichaffectsonein3,300boys.The muscledamageandweaknesswhichoccurswiththis diseaseleadstoaprogressivedeclineintheboy sability toperformeverydaytasks,suchasclimbingstairsand walkingshortdistances[2-4].Disruptiontothelivesof childrenwithDMDandtheirfamiliesbeginsasearlyas agethreewhenmuscleweaknessinterfereswithdaily activities.Astheweaknessprogresses,theboysoftenbecomeconfinedtowheelchairsearlyintheseconddecade oflife.Endstagecardiacandrespiratorycomplicationsleadtodeathwhichfrequentlyoccursaroundthe ageof20[6-8].Overall,DMDleadstoalossoffunctionalindependenceanddeteriorationinthequalityof lifeforboththechildrenandtheirfamilies[9-13]. Itisimperativetodeveloptechniqueswhichcanbe usedtofollowtheprogressionofthisdiseaseaswellas theefficacyofanytherapeuticinterventions.Traditional measuresusedtofollowDMDaretypicallyclinicalmeasuresofskeletalmusclestructureandfunction[14-17]. Theseoutcomemeasuresincludemusclestrength,manualmuscletesting,rangeofmotion,forcedvitalcapacity, anthropometrictests,timedfunctionaltestsandthe6 minwalk.Inaddition,therearealsoinvasivetechniques, suchasmusclebiopsy,andnoninvasivetechniques,such asmagneticresonanceimaging,whichhavebeenusedto followthestructuralandcompositionalchangesthat occurwiththeprogressionofDMD[18,19].Although thesemeasuresrepresentthecurrentmodelsonwhich clinicalprogressionofthediseaseisbased[20,21],such measurementsmaynotfullycapturetheimpactofthe diseaseonreallifeactivities.Themedicalcommunity haslongassumedthatdisabilitydirectlycorrelateswith themeasurementsmadeinaclinicalsetting.However,it hasbeenshownthatmeasuresofpathophysiologyand motorfunctionassessedintheclinicdonotnecessarily relatetoorpredicthowpatientsdealwithlifesituations [22-24].Clinicalmeasuresareoftendisconnectedfrom thecontextandsynergyofeverydaylife.Therefore,perhapsothernontraditionaloutcomemeasureswouldalso bevaluableinfollowingtheprogressionofDMD. Oneoutcomemeasurewhichcouldbeusedto evaluatetheabilityofboyswithDMDtomanagereal lifesituationsistodeterminetheirdegreeof participation invariousactivities.TheInternationalClassificationofFunctioning,Disability,andHealth-Children andYouthVersion(ICF-CY)adoptedbytheWorld HealthOrganization(WHO)(Figure1)identifies participationasanimportantoutcomeofhealth.Participationisdefinedasdirectengagementinalife situationincludingactivitiesofpersonalcare,mobility, socialrelationships,education,recreationandleisure, spirituality,andcommunitylife[25,26].Ithasbeen reportedthatchildrenwithphysicaldisabilitiesengage inlessvariedactivitiesthanhealthychildren[27-30]. Tothebestofourknowledge,participationlevels amongchildrenwithDMDandchangesinthepatternsofparticipationwithageanddiseaseprogression havenotbeeninvestigated.Therefore,thereisaneed toquantifyparticipationinboyswithDMDandthe effectparticipationmayhaveontheirqualityoflife throughoutthecourseofthedisease. Qualityoflife(QoL)measureshaveoftenbeenusedin thehealthcarefieldtocomparediseases,determinethe effectsofanillness,andmeasuretheoutcomesof treatmentsandclinicaltrials[32,33].ItispossiblethatQoL measurescanshednewinsightintopatientoutcomesthat traditionalphysicalmeasuresmaynotbeabletoassess [11,33-35].Ithasbeenreport edthatchildrenwithchronic illnessestypicallyscorebelowhealthychildreninQoL Body Function & Structure Pathophysiology Stage of disease Strength Activity Clinical Assessments Functional Mobility Participation Physical Recreational Social Environmental Factors Personal Factors Health Status Figure1 InternationalClassificationofFunctioning,DisabilityandHealth-ChildrenandYouthVersion(ICF-CY). Bendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page2of9 http://www.hqlo.com/content/10/1/43
assessments,althoughpatientswithprogressivediseases suchasDMDhavebeenexcludedfrommostcomparative studies[36,37].Surprisingly,thereislittleinformationon theQoLofchildrenwithDMDdespiteparentsreporting qualityoflifeissuesasanimportantchallengefortheir children[38,39].Theprogressivedeclineinstrengthand lossoftheabilitytoparticipateinactivitieswiththeirpeers canleadtosocialexclusionandisolationfortheseboys. Thesefactorsmayhaveasignificantimpactonhowboys withDMDperceivetheirqualityoflife. Theobjectivesofthisinvestigationwere1)tocompare boyswithDMDwithanunaffectedage-matchedpopulationofboyswithregardtoparticipationinreallifeactivities andperceivedqualityoflife,2)todeterminethedifferences inparticipationinactivitiesandperceivedqualityoflifein youngerandolderboyswithDMDandunaffectedboysto exploretheeffectsofdiseaseprogression,and3)todetermineifthereisarelationshipbetweenparticipationinactivitiesandperceivedqualityoflifeinyoungerandolder boyswithDMDandunaffectedboys.Thiswasaccomplishedbyusingtwoself-reportoutcomemeasures,the Children sAssessmentofParticipationandEnjoyment (CAPE)andthePediatricQualityofLifeInventoryTM4.0 (PedsQL).MethodsInourstudywecollecteddatafromacohortofboys participatinginalargernaturalhistorystudyexploring biomarkersofdiseaseprogressioninDuchennemuscular dystrophy.Ourstudyinvestigatedself-reportofparticipationlevelsandQoLinboyswithDMDcomparedto unaffectedage-matchedboys.FiftyboyswithDMD(validatedthroughmedicalreportusingmoleculargenetic testingand/orimmunohistochemicalstainingfrom musclebiopsy)andtheirparent(s)volunteeredtoenroll inthisstudy.Twenty-fiveunaffectedage-matchedboys wererecruitedfromthegeneralpopulationforcomparisonsinparticipationandQoL.Unaffectedboyswere relativelysedentary,inthattheydidnotparticipatein sportspecifictrainingmorethan2timesperweek.All boysandtheirparentsparticipatedinpersonatoursite. Theboysrangedinagefrom5to15years.Threeboys withDMDwhowerenonambulatorywereincludedin thisstudy;allotherswereambulatoryatthetimeof testing.ThestudywasapprovedbytheUniversityof FloridaInstitutionalReviewBoard(IRB129-2008).Written,informedconsentwasobtainedfromtheparent(s), andwrittenassentwasobtainedfromeachparticipant. Followinginformedconsent,theboyscompletedtwo paper/pencilself-reportassessmentswhichfocusedon participationinphysical,recreationalandsocialactivities andperceivedqualityoflife.Assessmentsofparticipation werecompletedwiththeassistanceoftheirparent(s).InstrumentsParticipationwasmeasuredbythe Children sAssessment ofParticipationandEnjoyment(CAPE) .TheCAPE isdesignedtoexaminehowchildrenandyouthparticipate ineverydayactivities.ScoresontheCAPEaredividedinto fivedimensions:1) Diversity,thenumberofactivitiesperformedoverall;2) Intensity,thefrequencyofperforming theactivity;3) WithWhomtheactivityisperformed;4) Wheretheactivityisperformed;and5)howmuch Enjoymentthechildgetsfromtheactivity.Additionally, activitiesaredividedintothefollowingdomains:physical, recreational,social,skill-based,andself-improvement. ThreeactivitydomainsoftheCAPEwereusedinourcalculations(physical,recreationalandsocialactivities). Physicalactivitiesincludedsuchitemsasplayingteam sports,bicycling,andactivelyusingplaygroundequipment.Recreationalactivitiesincludedreading,playing cardsorplayingvideo/computergames.Socialactivities includedvisitingfriends,goingtothemovies,andcooking. ReliabilityandvalidityoftheCAPEwereestablished usingdatafromalongitudinalstudyinvolving427childrenwithphysicaldisabilities.Althoughvalidation studieswiththeCAPEdidnotincludechildrenwith progressivediseases,suchasDMD,otherdiagnoses whichresultinmuscleweaknessandmotordifficulties wereincluded(i.e.,cerebralpalsy,amputation,muscular disorders,neuropathy,orthopaedicconditions,vascular braindisorders).Inaddition,theCAPEwasdesignedto beadirectmeasureofparticipationasreflectedbythe WHO sICFmodel.TheCAPEdocumentswhata childdoesintheireverydaylife,notthechild scompetenceorthedegreeofsupportrequiredtoparticipatein theactivity.ThereforeitwasfelttheCAPEmeasure wouldadequatelycapturetheboyswithDMDinvolvementinlifesituations. QualityofLife(QoL) wasassessedthroughthe PediatricQualityofLifeInventoryTM4.0(PedsQL), whichisdesignedtomeasurethecoredimensionsofhealth asdelineatedbytheWHO(physic al,emotional,social),as wellasschoolfunctioning,andhasbeendeterminedtobe athoroughandreliablemeasureofQoLinchildren [36,37,41].Genericqualityoflifeinstrumentshavefrequentlybeenusedaspatientreportedoutcomemeasures, andtheiruseencouragedtoe xploretheclinicalmeaningfulnessofachangeinmoretraditionalclinicalmeasuresof bodysystemsandoverallfunction[26,33].GenericQoL measurementsprovidevaluableinformationforcomparing populations,butmaynotbesensitiveenoughtodetect changenecessaryforatreatmentbasedclinicaltrial. ThePedsQLTM4.0haspreviouslybeenusedtoevaluate patient-perceivedwellbeinginboyswithDMDandunaffectedcontrolsandtoinvestigateagreementbetween boyswithDMDandtheirparentswhenreportingquality oflife[13,44].ThedatafortheGenericCoreScaleswereBendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page3of9 http://www.hqlo.com/content/10/1/43
derivedfromthePedsQLTM4.0fieldtest.Generic CoreScalesincludedchildrenwhoarehealthy,acutelyill, andchronicallyill.StatisticalanalysisAllstatisticalanalyseswereperformedusingstatistical softwarePASWversion18.0forWindows(PASWInc., Chicago,IL).TheMann Whitney U -testwasusedfor groupcomparisonsandtheSpearman srankcorrelation coefficienttestwasusedfornon-parametricanalysisof correlations.Ap-valueoflessthanorequalto0.05was consideredstatisticallysignificant.Inouraimofexploringthedifferencesinparticipationinlifeactivitiesand perceivedQoLbetweenyoungerandolderunaffected boysandboyswithDMD,ap-valueoflessthanorequal to0.01wasconsideredstatisticallysignificantduetothe multiplenumberofanalysesperformed.ResultsCharacteristicsofboyswithDMDandunaffectedagematchedboysAcomparisonofthecharacteristicsoftheboyswithDuchennemusculardystrophy(DMD)andtheunaffected age-matchedboysusedinthisstudyisshowninTable1. Theagesandweightsoftheboysinbothgroupswere comparable.However,boyswithDMDwereshorterin heightandhadahigherbodymassindex(BMI)thanunaffectedboys.Onepossiblereasonforthedecreasein heightandhigherBMImaybethefactthatallboysin theDMDgroupweretakingsteroids.Itisknownthat administrationofsteroidsmayresultinweightgainand shortstature.AcomparisonoftheabilitytoparticipateinlifeactivitiesandtheirperceivedQoLwasmade betweenthesetwogroups,andtheresultsarepresented below.ParticipationandQoLinboyswithDMDVsunaffected boysParticipationinlifeactivitiesforeachgroupwasassessed usingtheChildren sAssessmentofParticipationandEnjoyment(CAPE),aself-reportoutcomemeasure.The resultsweredividedintofourcategories(Figure2).Intensityisameasureofthefrequencyofparticipationin chosenactivitiesvaryingfromnoparticipation(score0) toonceinthelast4months(score1)todaily(score7). Thetotalnumberofactivitiesinwhichanindividualparticipatesin(Diversity)andintensityscoresareusedto computescoresforthethreedifferenttypesofactivities: physical,recreational,andsocial.Therangeofactivity scoresisfrom0(lowestparticipation)to7(highestparticipation).Theresultsshowedlowerparticipationlevels inphysicalactivitiesinDMD(p < .001),butnosignificantdifferencesbetweenboyswithDMDandunaffected boysindiversityoranyoftheothercategories(intensity, recreationalorsocialactivities). TheperceivedQoLforeachgroupwasassessed usingthePediatricQualityofLifeInventoryTM4.0 (PedsQL),alsoaself-reportoutcomemeasure.These responsesweredividedintofoursubscales:physical, emotional,social,andschool-related.Inaddition,a totalQoLcompositescorewasalsoincluded(Figure3). Therangeofscoresisfromzero(lowestQoL)to100 (highestQoL).Therewerelowerscoresforboyswith DMDthantheunaffectedgroupinphysical,social, school-related,andtotalcompositequalityoflife responses.Therewerenosignificantdifferencesbetweengroupsintheresponsesrelatedtoemotionalfactors.Theseresultsdemonstratethat,ingeneral,the perceivedQoLisdiminishedinboyswithDMD.ParticipationandQoLinyoungerandolderboysToassesstheeffectsofdiseaseprogression,theboys withDMDandunaffectedboysweredividedintotwo agegroups,i.e.,lessthan10yearsand10yearsorolder. Theageof10yearswasselectedbecauseofthedisease progressionandthemuscleandfunctionalchangesthat reportedlyoccurforboyswithDMDaroundthisage,includingtheabilitytorisefromthefloor,walkupstairs orambulate[5,17,19].Alldemographicsforthesetwo agegroups(age,height,weight,BMI)werestatistically significantlydifferentatp < .001.ForboyswithDMD, thereweresignificantdifferencesbetweenthetwoage groupsinCAPEscoresofdirectparticipationinsocialactivities(p 0.01) andatrendtowardsignificanceinoverall frequencyofparticipationinallactivities( p 0.05),butno differencesindiversityofactivitiesorparticipationin physicalorrecreationalactivities.Nodifferenceswere observedbetweenthesetwoDMDagegroupsinselfreportofQoLinanyofthesubscalescoresorthetotal compositescoreofthePedsQLTM(Table2).Theseresults demonstratethatoverall,olderboyswithDMDparticipate inavarietyofactivities,butlessoftenthantheiryounger peers.Moreimportantly,engagementinsocialactivities declinedsignificantlyforourolderboyswithDMD. Interestingly,perceivedqualityoflifedidnotvarybetweenthetwoDMDagegroups.Forourunaffected group,nosignificantdifferenceswerefoundbetween thetwoagegroupsinanyPedsQLTMsubscalescoresor totalcompositescore(Table2). Table1CharacteristicsofDMDandunaffectedagematchedsubjectsDMD(n=50)Unaffected(n=25) Age8.9(2.4)8.4(2.1) Weight(kg)32.3(10.5)31.1(10.2) Height(m)122.6(12.5)142.5(11.3)** BMI(kg/m2)19.5(3.4)16.7(3.4)**p .05;**p .01.Bendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page4of9 http://www.hqlo.com/content/10/1/43
DifferencesbetweentheyoungerboyswithDMDand theyoungerunaffectedboyswereobservedintheCAPE areaofphysicalparticipation,aswellasthePedsQLTMphysicalsubscaleandtotalcompositescore(allsignificantatp 0.000).Forouroldercohort( 10years),boys withDMDscoredsignificantlylowerinthephysicaland socialdomainsoftheCAPE,aswellasthePedsQLTMphysicalandsocialsubscalesandthetotalcomposite score(Table2).RelationshipbetweenparticipationandQoLAstheresultsabovedemonstrate,participationinactivitiesthatweresocialinna turedeclinedfortheolder cohortofboyswithDMD;self-reportofQoLdidnot differbetweenthetwoDMDorunaffectedagegroups. CorrelationalanalysesshowednosignificantrelationshipbetweenoverallparticipationandperceivedQoL ineitheragegroupofboyswithDMDorunaffected boys. *** Figure2 BaselineCAPEResponsesbyDMD(n=50)andUnaffectedAge-MatchedSubjects(n=25). CAPE,Children sAssessmentof ParticipationandEnjoymentcollectioninstrument.DMD,Duchennemusculardystrophy;Rangeofscores(Intensity0 7;PhysicalActivities0 7; RecreationalActivities0 7;SocialActivities0 7).Dataarepresentedasmeans standarddeviations.***p < 0.001. *** *** *** ** Figure3 BaselinePedsQLResponsesbyDMD(n=50)andUnaffectedAge-MatchedSubjects(n=25) DMD,Duchennemuscular dystrophy;PedsQLTM,PediatricQualityofLifecollectioninstrument;Rangeofscores0 100.Dataarepresentedasmeansstandarddeviations.*p < 0.05;**p < 0.01;***p < 0.001. Bendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page5of9 http://www.hqlo.com/content/10/1/43
DiscussionInthisstudywecomparedparticipationinlifeactivities andperceivedQoLbetweenboyswithDMDandanagematchedpopulationofunaffectedboys.Theresults showedthatparticipationinphysicalactivitieswassignificantlylowerinboyswithDMDthanunaffectedcontrols,althoughotherparticipationmeasuresweremuch thesameashealthyboys.Furthermore,perceivedQoL wasmarkedlydiminishedinchildrenwithDMDrelative tounaffectedcontrols.Anotherobjectiveofthisstudy wastocompareyoungerboystoolderboysinboththe DMDandunaffectedcohortstoexplorebothwithin groupandbetweengroupdifferencesinparticipation andQoL.Forwithingroupdifferences,wefoundthat theamountoftimeboyswithDMDengageinanactivity (frequency),aswellasparticipationinsocialactivities, declinedforouroldercohortbuttherewasnodeclinein participationobservedforourolderunaffectedboys.No differencesinperceivedQoLwereobservedbetweenthe youngerandolderboyswithDMDortheunaffected boys.Significantbetweenagegroupdifferenceswere observedamongtheboyswithDMDandtheunaffected controls.Comparisonsbetweenouryoungerboyswith DMDandouryoungerunaffectedboysshowedlower scoresindiversityofactivitiestheyparticipatein,aswell asparticipationinphysicalactivities.Qualityoflife scoreswerelowerinthephysicalsubscaleaswellasthe overalltotalcompositescore.Forourolderboyswith DMD,lowerscoreswerereportedinbothphysicaland socialparticipation,aswellasqualityoflifesubscalesof physical,socialandtotalcompositescorescomparedto ourolderunaffectedboys.Nodifferenceswereobserved inthePedsQLTMsubscalesofemotionalorschoolrelated QoLforourolderboys.Finally,nocorrelationswere observedbetweenreportsofparticipationandQoLin thesetwogroups. Ourstudyisoneofthefirsttoexploreself-reportof participationinactivitiesinapopulationofboyswith DMD.Theresultsdemonstratedthat,overall,theboys withDMDchosediverseactivitiesinwhichtoparticipate andthattheywereinvolvedintheirchosenactivitiesas frequentlyashealthyboys.However,theactivitiesof choiceforboyswithDMDwerelessphysicalinnature thanunaffectedboystheirage.Itcertainlycomesasno surprisethatchildrenwithmuscularweaknessareless likelytoparticipateinphysicalactivities,especiallyas theyage[46,47].Interestingly,physicalactivityfor healthyboyshasbeenreportedtodeclineduringlater childhoodoradolescencestages[48,49],althoughwedid notobserveadeclineinourunaffectedgroupofboys.In contrast,thisage-relateddeclineinphysicalactivitiesfor unaffectedboysdoesnotappeartobeduetothebodily demandsoftheactivity[49,50].Moreover,physicalactivity participationistypicallyhighforyoungerunaffectedboys ,butwassignificantlylowerinouryoungerboyswith DMD. InboyswithDMD,participationinsocialactivities,such asvisitingfriends,goingtopartiesorgoingtothemovies wassignificantlyloweraftertheageof10years.Thisis oftentheagewhenboyswithDMDexperienceadecrease inmotorabilities,suchasambulation[5,46]andmay, therefore,havelessopportunityforcommunity-based socialengagement.It simportanttonotetheconnection betweenphysicalabilitiesandsocialengagement.Poor Table2BaselineCAPEandPedsQLTMresponsesbyDMDandunaffectedbasedonagegroups:differenceswithinand betweengroupsInstrumentsDMD(n=50)Unaffected(n=25)Pvalue Between Groups < 10years Pvalue Between Groups 10 years < 10years (n=27) 10 years (n=23) < 10years (n=13) 10years (n=12) CAPEDiversity30.1(5.2)27.6(5.4)33.3(7.1)30.1(4.2)0.050.19 CAPEIntensity2.7(0.6)2.4(0.5)*3.2(0.8)2.6(0.5)0.180.68 CAPEPhysical1.4(0.7)1.3(1.1)2.9(0.9)2.5(0.9)0.000.01 CAPERecreational4.9(1.0)4.6(1.1)5.2(0.7)4.8(0.7)0.380.42 CAPESocial3.4(0.9)2.4(0.8)**3.1(0.7)3.0(0.9)0.850.02 PedsQLPhysical68.1(16.7)61.6(21.2)87.8(11.5)85.3(12.5)0.000.00 PedsQL Emotional 63.2(17.6)71.8(19.8)73.1(18.8)73.6(19.1)0.130.83 PedsQLSocial68.5(22.9)65.9(23.5)79.9(21.3)86.4(17.9)0.140.03 PedsQLSchool64.5(20.7)67.7(18.0)78.9(13.9)81.4(13.7)0.180.05 PedsQLTotal Composite 66.2(11.4)66.7(16.9)82.7(13.1)81.6(12.7)0.000.02DMD, Duchennemusculardystrophy; CAPE ,Children sAssessmentofParticipationandEnjoymentcollectioninstrument; CAPE, Rangeofscores(Diversity0 55; Intensity0 7;PhysicalActivities0 7;RecreationalActivities0 7;SocialActivities0 7); PedsQL ,PediatricQualityofLifecollectioninstrument ;PedsQL ,Rangeof scores0 100.Dataarepresentedasmeansstandarddeviations.*p < .05;**p < .01.Bendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page6of9 http://www.hqlo.com/content/10/1/43
motorskillshavebeenassociatedwithpeerrelationship difficulties,lowerpeerregardandgreaterlikelihoodof sufferingfromwithdrawal.Activelyengagingin physicalactivities,suchasteamsportsorplayingwith othersontheplayground,helpschildrenformpeerrelationshipsandexperienceasenseofself-worthand belongingtoagroup[30,40,51,52].Unfortunately,little isknownaboutthesocialengagementofchildrenwith DMD.Althoughparentsmoreoftenreportprolonging ambulationasthemostimportantfactorindealingwith DMD[39,53],theresultingemotionalchallengesof DMDandtheincreasingsocialneedsofboysastheyage isalsoofgreatconcern[39,54]. Ourstudyalsousedself-reportmeasurestodetermine theperceivedQoLoftheboyswithDMDrelativetounaffectedcontrols.TheboyswithDMDreportedlower physical,socialandschool-relatedscores,resultingin significantlylowertotalcompositeQoLscores.However, therewasnoeffectofthediseaseintheemotionalareaof QoL,evenastheboysaged.Thedifferencesinthese responsesmaybeduetothetypesofquestionsusedinthe PedsQLTMassessment.Thequestionsaddressedinthe physical,social,andschool-relatedareasarebasedondifficultiesinactualperformance,suchasphysicalactivities, makingfriends,ormissingschoolduetomedical/physicianappointments.Ontheotherhand,theemotionalsubscaleofthePedsQLTMconsistsofquestionsaboutfeelings ofsadness,anger,andfear.Thesemaybeemotionsthat areevidentinmostchildrentosomedegreeandmaynot necessarilybeexaggeratedbythedisease.Itisinteresting tonotethatalthoughQoLscoresforboyswithDMDwere significantlylowerthanforunaffectedboys,thesescores didnotnotablydecreasewithinthecohortofchildrenwith DMDwhenthediseasehastypicallyprogressed.Other researchershavealsoreportednochangesinQoLrelated todiseaseprogression[11,12,43,55].Inalongitudinal study,Simonandcolleagues(2010)usedtheLifeSatisfactionIndexforAdolescents,whichtheydeterminedtobea moreeffectiveinstrumentforboyswithDMDbasedonits limitedfocusonphysicalabilities.Nocomparisonswere madewithunaffectedboys,butthecohortof95boyswith DMDdidnotshowasignificantdecreaseandnolossof QoLwasobservedamongtheboysmostaffectedbythe progressionofthedisease.Abreschetal.[56,57] determinedthatphysicalfunctioningandlevelofdisability alonedidnotalteroverallQoL,afindingthatwasalso reportedbyKohleretal.usingtheShort-Form36of themedicaloutcomequestionnaire.Finally,basedon PedsQLTMscoresestablishedandvalidatedinavarietyof patientpopulations[37,58],theoverallscoresforourcohortofboyswithDMDwerelowerthanscoresfromchildrenwithothermajorchronichealthissues. Inourstudy,wedidnotfindarelationshipbetween CAPEparticipationscoresandPedsQLTMqualityoflife scoresforunaffectedboysorboyswithDMD,although relationshipsbetweenQoLandspecificclinicalmeasures thataretypicallyassessedinboyswithDMDhavebeen observed.Brayetal.foundrelationshipsbetween age,steroiduse,physicalfunctioningandQoLinDMD. McDonaldetal.utilizedparent-proxyreportand founddirectrelationshipsbetweenthephysicaldomains ofQoL,age,andsuchclinicalassessmentsassupineto stand,walk/run10metersandwalkup4stairs.Findings fromotherstudiesinDMDsupportthethoughtthat meaningfulanddevelopmentallyimportantlifeactivities, suchasplayingwithandactivelyengagingwithfriends, mayberelatedtoQoL[11,59].Itisdifficulttoexplain thesevaryingresultsandwhywedidnotfindacorrelation betweenparticipationandQoL.Althoughoursamplesize wassmall,itwouldalsoappearthatQoLiscomplexand moreglobalinnaturethanthestraightforwardandexplicit reportofactualparticipation.AsColvertheorized,QoL cannotbemeasureddirectly,butonlycapturedthrougha varietyofquestionsthatseektoplacevalueonaparticular variable.Therefore,QoLisaconceptandissubjective ,whileparticipationisareallifeexperienceandisobjective[61-63].Finally,ourresultsmaydifferfromsome studiesbecausewechosetousechildreportinlieuofparentproxyreporttoobtainafullunderstandingofthechildren sperceptionoftheirQoL.Literatureinthisarea showsthatparentsandchildrenoftendifferintheiragreementofthechild sQoL[13,44,64],butthelargerissue appearstobewhetherachildiscapableofself-report [65,66].Wetookthestance,asothershave,thatchildren canprovidevaluableinformationabouttheirhealthand thatqualityoflifeissubjectiveandthereforeshouldbea person sindividualview[33,61,65,66].LimitationsWeacknowledgethereareafewlimitationstoourstudy. AlthoughourpopulationofboyswithDMDisrare,our samplesizemaybeconsideredrelativelysmall,especially whenbrokenintoagegroups.Moreover,asthiswasnota longitudinalstudy,comparingdifferentagegroupsmaynot begivingusinformationaboutchangesasthediseaseprogresses.Lastly,althoughthePedsQLTMisathoroughly developedgenericmeasurethatisbrief,easytounderstand, andcapturesinformationrelevanttobothchildrenwitha disease/illnessandunaffectedchildren,weacknowledge thatthePedsQLTMdomainsarelimited,arenotdesigned toassessafullrangeoffunctioningandarenotspecificto childrenwithaneuromusculardisorder.ConclusionsAlthoughaprogressivedisease,suchasDMD,influences thephysicalabilitytoparticipateinmanyactivities,it s importanttoacknowledgethatrestrictionsinBendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page7of9 http://www.hqlo.com/content/10/1/43
participationshouldnotinevitablyarisefromthisorany childhooddisease.OptimummanagementofDMD requiresamultidisciplinaryapproachthatfocusesonanticipatoryandpreventivemeasuresaswellasactive interventionstoaddresstheprimaryandsecondarycomplicationsresultingfromthedisorder.Suchamultidisciplinaryapproachwouldbenefitfromusinga frameworktoconceptualizetheprocessoflivingwitha progressivedisease.TheICF-CYprovidesaconceptualframeworkandspecificterminologythatfacilitatesinvestigationoftheconsequencesofchronicillnessand impairmentinchildrenandyouth.TheICFmodelprovides areasofinterventionthatcanenhancetheparticipationof childrenwhosefunctionalwell-beingisatrisk.Interventionsthatfocusonmultipleaspectsofthechildandaddressparticipationaffordchildrentheopportunityto continuetoengageinageanddevelopmentallyappropriate activities,andultimatelymayservetopromoteoverall health[61,62].Resultsfromourstudyunderscoretheneed tofurtherevaluateactivitiesthatchildrenelecttoparticipateintoobtainanaccurateaccountofachild slevelof participationandhowparticipationchangesthroughout thecourseofadisease.Additionally,exploringhowparticipationmayrelatetospecificclinicaltestsmaygiveus abetterunderstandingofareasofintervention.Competinginterests Theauthorsdeclarethattheyhavenocompetinginterests Acknowledgements Theauthorswouldliketoliketothankthechildrenandfamilieswhogave theirtimetoparticipateinthisstudy.WewouldalsoliketoacknowledgeDr. PhilMilesforhiseffortsindraftingandrevisingthemanuscript.Dr.Bendixen iscurrentlyfundedthroughanNIH NICHDK01mentoredcareer developmentgrant(5K01HD064778)andisinPhaseIIofanNIHK12 institutionalgrant(K12HD055929).Additionalfundingforrecruitmentand participantsupportwasprovidedthroughParentProjectMuscularDystrophy andtheMuscularDystrophyAssociation(PI,K.Vandenborne)andagrant throughaSenatorPaulD.WellstoneMuscularDystrophyCooperative ResearchCenter(PI,L.Sweeney). Authordetails1ResearchAssistantProfessor,DepartmentofOccupationalTherapy, UniversityofFlorida,Gainesville,FL32611,USA.2ClinicalAssistantProfessor, DepartmentofPhysicalTherapy,UniversityofFlorida,Gainesville,FL32611, USA.3ResearchAssistantProfessor,DepartmentofPhysicalTherapy, UniversityofFlorida,Gainesville,FL32611,USA.4Chair,DepartmentofPhysical Therapy,CollegeofPublicHealth&HealthProfessions,UniversityofFlorida, Gainesville,FL32611,USA. Authors contributions RMBconceivedanddesignedthestudy,acquiredthedata,analyzedand interpretedthedataanddraftedandrevisedthemanuscript.CSrecruited thesubjects,scheduledtimesfortheevaluations,andhelpedtodraftand revisethemanuscript.DJLparticipatedinthedesignofthestudyand helpedtodraftandrevisethemanuscript.KVistheprincipalinvestigatorof thelargerstudyfromwhichthispilotdatawascollected;KVparticipatedin thedesignofthestudyandwasinvolvedinthedraftingofthemanuscript andrevisingforcriticallyimportantintellectualcontent.Allauthors participatedsufficientlyintheworktotakepublicresponsibilityfor appropriateportionsofthecontent.Allauthorsreadandapprovedthefinal manuscript. Received:26September2011Accepted:30April2012 Published:30April2012 References1.DeconinckN,DanB: PathophysiologyofDuchennemusculardystrophy. PediatrNeurol 2007, 36 (1):1 7. 2.HoffmanEP,BrownRH,KunkelLM: Dystrophin:Theproteinproductofthe Duchennemusculardystrophylocus. Cell 1987, 51: 919 928. 3.SussmanM: Duchennemusculardystrophy. JAmeAcadOrthopSurg 2002, 10 (2):138 151. 4.TidballJG,Wehling-HenricksM: Theroleoffreeradicalsinthe pathophysiologyofmusculardystrophy. JApplPhysiol 2007, 102 (4):1677 1686. 5.EmeryA,MuntoniF: DuchenneMuscularDystrophy .3rdedition.Oxford: OxfordUniversityPress;2003. 6.BushbyK,FinkelR,BirnkrantDJ,CaseLE,ClemensPR,CripeL,KaulA, KinnettK,McDonaldC,PandyaS,PoyskyJ,ShapiroF,TomezskoJ, ConstantinC: DiagnosisandmanagementofDuchennemuscular dystrophy,part2:Implementationofmultidisciplinarycare. LancetNeurol 2010, 9 (2):177 189. 7.DarrasBT,MenacheCC,KunkelLM: Dystrophinopathies .In Neuromuscular DisordersofInfancy,ChildhoodandAdolescence-AClinician sApproach .Edited byJonesHR,DeVivoDC,DarrasBT.Amsterdam:ButterworthHeinemann; 2003:649 700. 8.HoffmanEP: Dystrophinopathies .In DisordersofMuscle .KarpatiG,Hilton-Jones D,GriggsRCthedition.Cambridge:CambridgeUniversityPress;2001:385 482. 9.WitteRA: Thepsychosocialimpactofaprogressivephysicalhandicap andterminalillness(Duchennemusculardystrophy)onadolescentsand theirfamilies. BrJMedPsychol 1985, 58: 179 187. 10.GagliardiBA: TheimpactofDuchennemusculardystrophyonfamilies. OrthopNurs 1991, 10 (5):41 49. 11.GrootenhuisMA,deBooneJ,vanderKooiAJ: Livingwithmuscular dystrophy:healthrelatedqualityoflifeconsequencesforchildrenand adults. HealthandQualityofLifeOutcomes 2007, 5 (31):1 8. 12.BaiardiniI,MinettiC,BonifacinoS,PorcuA,KlersyC,PetraliaP,BalestracciS, TarchinoF,ParodiS,CanonicaGW,BraidoF: QualityoflifeinDuchenne musculardystrophy:Thesubjectiveimpactonchildrenandparents. J ChildNeurol 2011, 26(6):707 713. 13.BrayP: Thank,RyanMM,NorthKN,EverettA:Health-relatedqualityof lifeinboyswithDuchennemusculardystrophy:Agreementbetween parentsandtheirsons. JChildNeurol 2010, 25 (10):1188 1194. 14.BrookeMH,GriggsRC,MendellJR,FenichelGM,ShumateJB,PellegrinoRJ: ClinicaltrialsinDuchennedystrophy.I.Thedesignoftheprotocol. MuscleNerve 1981, 4: 186 197. 15.ScottOM,HydeSA,GoddardC,DubowitzV: Quantificationofmuscle functioninchildren:aprospectivestudyinDuchennemuscular dystrophy. MuscleNerve 1982, 5: 291 301. 16.McDonaldCM,HenricsonEK,HanJJ,AbreschRT,NicoriciA,ElfringGL, AtkinsonL,RehaA,HirawatS,MillerLL: The6-minutewalktestasanew outcomemeasureinDuchennemusculardystrophy. MuscleNerve 2010, 41 (4):500 510. 17.BeenakkerEA,MauritsNM,Fock JM,BrouwerOF,vanderHoevenJH: Functional abilityandmuscleforceinhealthychildrenandambulantDuchenne musculardystrophypatients. EurJPaediatrNeurol 2005, 9: 387 393. 18.CossuG,SampaolesiM: NewtherapiesforDuchennemusculardystrophy: Challenges,prospectsandclinicaltrials. TrendsMolMed 2007, 13 (12):520 526. 19.ChamberlainJ,RandoT: DuchenneMuscularDystrophy:Advancesin Therapeutics .NewYork:Taylor&FrancisGroup;2006. 20.McDonaldCM,AbreschRT,CarterGT,FowlerWM,JohnsonER,KilmerDD, SigfordBJ: Profilesofneuromusculardiseases.Duchennemuscular dystrophy. AmJPhysMedRehabil 1995, 74 (5Suppl):S70 S92. 21.ScottE,MawsonSJ: MeasurementinDuchennemusculardystrophy: considerationsinthedevelopmentofaneuromuscularassessmenttool. DevMedChildNeurol 2006, 48: 540 544. 22.LollarDJ,SimeonssonRJ: Diagnosistofunction:classificationforchildren andyouths. JDevBehavPediatr 2005, 26 (4):323 330.Bendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page8of9 http://www.hqlo.com/content/10/1/43
23.KeysorJJ,JetteAM,CosterW,BettgerJP,HaleySM: Associationof environmentalfactorswithlevelsofhomeandcommunity participationinanadultrehabilitationcohort. ArchPhysMedRehabil 2006, 87 (12):1566 1575. 24.JetteAM,KeysorJ,CosterW,NiP,HaleyS: Beyondfunction:predicting participationinarehabilitationcohort. ArchPhysMedRehabil 2005, 86 (11):2087 2094. 25.WorldHealthOrganization(WHO): InternationalClassificationofFunctioning, DisabilityandHealth:Children&YouthVersion .Switzerland:Geneva;2007. 26.WorldHealthOrganization(WHO): InternationalClassificationofFunctioning, DisabilityandHealth .Switzerland:Geneva;2001. 27.LawM,KingG,KingS,KertoyM,HurleyP,RosenbaumP,YoungN,HannaS: Patternsofparticipationinrecreationalandleisureactivitiesamong childrenwithcomplexphysicaldisabilities. DevMedChildNeurol 2006, 48: 337 342. 28.KingG,LawM,KingS,HurleyP,HannaS,KertoyP,RosenbaumP: Measuringchildren sparticipationinrecreationandleisureactivities: ConstructvalidationoftheCAPEandPAC. ChildCareHealthDev 2006, 33 (1):28 39. 29.MeijerSA,SinnemaG,BijstraJO,MellenberghGJ,WoltersWH: Social functioninginchildrenwithachronicillness. JChildPsycholPsychiatry 2000, 41 (3):309 317. 30.BrownM,GordonW: Impactofimpairmentonactivitypatternsof children. ArchPhysMedRehabil 1987, 68: 828 832. 31.HollingsworthH,MorganK,CuthbertJ,GreyD: Measureofqualityof participationinlifesituationsforpeoplewithmobilitylimitations .San Francisco:ICFSessionsatAPHAAnnualMeeting;2003. 32.AngeliniC: Theroleofcorticosteroidsinmusculardystrophy:Acritical appraisal. MuscleNerve 2007, 36: 424 435. 33.EiserC,MorseR: Themeasurementofqualityoflifeinchildren:pastand futureperspectives. JDevBehavPediatr 2001, 22: 248 256. 34.ZebrackiK,DrotarD: Painandactivitylimitationsinchildrenwith DuchenneorBeckermusculardystrophy. DevMedChildNeurol 2008, 50 (7):546 552. 35.NatterlundB,AhlstromG: Activitiesofdailylivingandqualityoflifein personswithmusculardystrophy. JRehabilMed 2001, 33:206 211. 36.VarniJW,LimbersCA,BurwinkleTM: Impairedhealth-relatedqualityoflifein childrenandadolescentswithchronicconditions:acomparativeanalysisof 10diseaseclustersand33diseasecategories/severitiesutilizingthe PedsQL 4.0GenericCoreScales. HealthQualLifeOutcomes 2007, 5: 43. 37.VarniJW,SeidM,KurtinPS: PedsQL 4.0:Reliabilityandvalidityofthe pediatricqualityoflifeinventory version4.0genericcorescalesin healthyandpatientpopulations. MedCare 2001, 39 (8):800 812. 38.WebbC: Parents'sperspectivesoncopingwithDuchenemuscular dystrophy. ChildCareHealthDev 2005, 31: 385 396. 39.BothwellJE,DooleyJM,GordonKE,MacAuleyA,CamfieldPR,MacSweenJ: Duchennemusculardystrophy Parentalperceptions. ClinPediatr 2002, 41: 105 109. 40.KingG,LawM,KingS,HurleyP,RosenbaumP,HannaS,KertoyM,YoungN: Children sAssessmentofParticipationandEnjoyment&PreferencesforActivities ofChildren .SanAntonio,TX:HarcourtAssessment,Inc;2004. 41.EiserC,MorseR: Areviewofmeasuresofqualityoflifeforchildrenwith chronicillness. ArchDisChild 2001, 84: 205 211. 42.ClarkS-A,EiserC: Themeasurementofhealth-relatedqualityoflife(QOL) inpaediatricclinicaltrials:asystematicreview. HealthQualLifeOutcomes 2004, 2: 66 70. 43.KohlerM,ClarenbachF,BoniL,BrackT,RussiE,BlochK: Qualityoflife, physicaldisability,andrespiratoryimpairmentinDuchennemuscular dystrophy. AmJRespirCritCareMed 2005, 172: 1032 1036. 44.McDonaldCM,McDonaldDA,BagleyA,ThomasSS,BuckonCE,HenricsonE, NicoriciA,SussmanMD: Relationshipbetweenclinicaloutcomemeasures andparentproxyreportsofhealth-relatedqualityoflifeinambulatory childrenwithDuchennemusculardystrophy. JChildNeurol 2010, 25 (9):1130 1144. 45.MoxleyRT,PandyaS,CiafaloniE,FoxDJ,CampbellK: Changeinnatural historyofDuchennemusculardystrophywithlong-termcorticosteroid treatment:implicationsformanagement. JChildNeurol 2010, 25 (9):1116 1129. 46.McDonaldCM: Physicalactivity,healthimpairments,anddisabilityinneuromusculardisease. AmJPhyMedRehabil 2002, 81 (Suppl11):108 120. 47.McDonaldCM,WidmanLM,WalshDD,WalshSA,AbreschRT: Useofstep activitymonitoringforcontinuousphysicalactivityassessmentinboyswith Duchennemusculardystrophy. ArchPhysMedRehabil 2005, 86: 802 808. 48.WallMI,CarlsonSA,SteinAD,LeeSM,FultonJE: Trendsbyageinyouth physicalactivity:Youthmediacampaignlongitudinalsurvey. MedSci SportsExerc 2011, 43: 2140 2147.Epubaheadofprint. 49.RiddochCH,BoAndersenL,WedderkoppN,HarroM,Klasson-Heggeb L, SardinhaLB,CooperAR,EkelundU: Physicalactivitylevelsandpatternsof 9-and15-year-oldEuropeanchildren. MedSciSportsExerc 2004, 36: 86 92. 50.TroianoRP,BerriganD,DoddKW,MasseLC,TilertT,McDowellM: Physical activityintheUnitedStatesmeasuredbyaccelerometer. MedSciSports Exerc 2008, 40: 181 188. 51.LiveseyD,LumMowM,ToshackT,ZhengY: Therelationshipbetween motorperformanceandpeerrelationsin9-to12-year-oldchildren. Child CareHealthDev 2010, 37 (4):581 588. 52.KinneyVB,CoyleCP: Predictinglifesatisfactionamongadultswith physicaldisabilities. ArchPhysMedRehabil 1992, 73: 863 869. 53.BoyerF,DrameM,MorroneI,NovellaJ-L: Factorsrelatingtocarerburden forfamiliesofpersonswithmusculardystrophy. JRehabilMed 2006, 38: 309 315. 54.HintonV,NereoN,FeeR,CyrulnikS: Socialbehaviorproblemsinboys withDuchennemusuclardystrophy. DevBehavPediatr 2007, 27: 470 476. 55.SimonVA,ResendeMB,SimonMA,ZanoteliE,ReedUC: Duchenne musculardystrophy:Qualityoflifeamong95patientsevaluatedusing theLifeSatisfactionIndexforAdolescents. ArqNeuropsiquiatr 2011, 69 (1):19 22. 56.AbreschRT,CarterGT,HanJJ,McDonaldCM: Newclinicalendpointsin rehabilitationmedicine:toolsformeasuringqualityoflife. AmJHosp PalliatCare 2009, 26(6):483 492. 57.AbreschRT,SeydenNK,WineingerMA: Qualityoflife.Issuesforpersonswith neuromusculardiseases. PhysMedRehabilClinNAm 1998, 9 (1):233 248. 58.HuangI-C,ThompsonLA,ChiY-Y,KnappCA,RevickiDA,SeidM,Shenkman EA: Thelinkagebetweenpediatricqualityoflifeandhealthconditions: EstablishingclinicallymeaningfulcutoffscoresforthePedsQL. Valuein Health 2009, 12 (5):773 781. 59.DijkersM,WhiteneckG: El-Jaroudi:Measuresofsocialoutcomesin disabilityresearch. ArchPhysMedRehabil 2000, 81 (Suppl2):63 80. 60.ColverA: Qualityoflifeandparticipation. DevMed&ChildNeuro 2009, 51: 656 659. 61.ForsythR,JarvisS: Participationinchildhood. ChildCareHealthDev 2002, 28: 277 279. 62.HeahT,CaseT,McGuireB,LawM: Successfulparticipation:thelived experienceamongchildrenwithdisabilities. CanJOccupTher 2007, 74: 38 47. 63.VarniJW: ThePedsQL .Measurementmodelforthepediatricqualityof lifeinventory. MedicalCare 1999, 37 (2):126 139. 64.WatersE,Stewart-BrownS,FitzpatrickR: Agreementbetweenadolescent self-reportandparentreportsofhealthandwellbeing:resultsofan epidemiologicalstudy. ChildCareHealthDev 2003, 29: 501 509. 65.RileyA: Evidencethatschool-agechildrencanself-reportontheirhealth. AmbulPediatr 2004, 4: 371 376. 66.RebokG,RileyAW,ForrestC,StarfieldB,GreenB,RobertsonJ,TamborE: Elementaryschool-agedchildren sreportsoftheirhealth:acognitive interviewingstudy. QualLifeRes 2001, 10: 59 70.doi:10.1186/1477-7525-10-43 Citethisarticleas: Bendixen etal. : Participationandqualityoflifein childrenwithDuchennemusculardystrophyusingtheInternational ClassificationofFunctioning,Disability,andHealth. HealthandQualityof LifeOutcomes 2012 10 :43.Bendixen etal.HealthandQualityofLifeOutcomes 2012, 10 :43Page9of9 http://www.hqlo.com/content/10/1/43
xml version 1.0 encoding utf-8 standalone no
mets ID sort-mets_mets OBJID sword-mets LABEL DSpace SWORD Item PROFILE METS SIP Profile xmlns http:www.loc.govMETS
xmlns:xlink http:www.w3.org1999xlink xmlns:xsi http:www.w3.org2001XMLSchema-instance
metsHdr CREATEDATE 2012-05-22T20:01:51
agent ROLE CUSTODIAN TYPE ORGANIZATION
name BioMed Central
dmdSec sword-mets-dmd-1 GROUPID sword-mets-dmd-1_group-1
mdWrap SWAP Metadata MDTYPE OTHER OTHERMDTYPE EPDCX MIMETYPE textxml
epdcx:descriptionSet xmlns:epdcx http:purl.orgeprintepdcx2006-11-16 xmlns:MIOJAVI
epdcx:description epdcx:resourceId sword-mets-epdcx-1
epdcx:statement epdcx:propertyURI http:purl.orgdcelements1.1type epdcx:valueURI http:purl.orgeprintentityTypeScholarlyWork
epdcx:valueString Participation and quality of life in children with
Duchenne muscular dystrophy using the
international classification of functioning, disability,
AbstractBackgroundDuchenne muscular dystrophy (DMD) is characterized by muscle damage and progressive loss of muscle function in male children. DMD is one of the most devastating genetically linked neuromuscular diseases for which there is currently no cure. Most clinical studies for DMD utilize a standard protocol for measurement exploring pathophysiology, muscle strength and timed tasks. However, we propose that examining broader components of health as emphasized by the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY) may be of great value to children and their families, and important outcomes for future clinical trials.MethodsFifty boys with DMD and 25 unaffected age-matched boys completed two self-report measures: the Children’s Assessment of Participation and Enjoyment and the Pediatric Quality of Life InventoryTM 4.0. We investigated differences between the two groups with regard to participation in life activities and perceived quality of life (QoL). Additionally, we compared participation in activities and QoL in both cohorts of younger and older boys.ResultsParticipation in physical activities was significantly lower in boys with DMD than unaffected boys. Perceived QoL was markedly diminished in children with DMD relative to unaffected controls, except in the emotional domain. The amount of time boys engage in an activity, as well as participation in social activities, declined for our older boys with DMD but no changes were observed for our older unaffected boys. For both groups, QoL remained constant over time.ConclusionsThe ICF-CY provides a conceptual framework and specific terminology that facilitates investigation of the consequences of impairment in children and youth. Our study is one of the first to explore participation in a cohort of boys with DMD. It was not surprising that activities of choice for boys with DMD were less physical in nature than unaffected boys their age, but the consequences of less social engagement as the boys with DMD age is of great concern. Results from our study underscore the need to further evaluate activities that children elect to participate in, with special emphasis on facilitators and barriers to participation and how participation changes throughout the course of a disease.
Bendixen, Roxanna M
Lott, Donovan J
http:purl.orgeprinttermsisExpressedAs epdcx:valueRef sword-mets-expr-1
http:purl.orgdcelements1.1language epdcx:vesURI http:purl.orgdctermsRFC3066
epdcx:sesURI http:purl.orgdctermsW3CDTF 2012-04-30
BioMed Central Ltd
Bendixen et al.; licensee BioMed Central Ltd.
Health and Quality of Life Outcomes. 2012 Apr 30;10(1):43
fileGrp sword-mets-fgrp-1 USE CONTENT
file sword-mets-fgid-0 sword-mets-file-1
FLocat LOCTYPE URL xlink:href 1477-7525-10-43.xml
sword-mets-fgid-1 sword-mets-file-2 applicationpdf
structMap sword-mets-struct-1 structure LOGICAL
div sword-mets-div-1 DMDID Object
!DOCTYPE art SYSTEM 'http:www.biomedcentral.comxmlarticle.dtd'
ui 1477-7525-10-43ji 1477-7525fm dochead Researchbibl title p Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Healthaug au ca yes id A1 snm Bendixenmi Mfnm Roxannainsr iid I1 email email@example.comA2 SenesacClaudiaI2 firstname.lastname@example.orgA3 LottJDonovanI3 email@example.comA4 VandenborneKristaI4 firstname.lastname@example.org ins Research Assistant Professor, Department of Occupational Therapy, University of Florida, Gainesville, FL, 32611, USAClinical Assistant Professor, Department of Physical Therapy, University of Florida, Gainesville, FL, 32611, USAResearch Assistant Professor, Department of Physical Therapy, University of Florida, Gainesville, FL, 32611, USAChair, Department of Physical Therapy, College of Public Health & Health Professions, University of Florida, Gainesville, FL, 32611, USAsource Health and Quality of Life Outcomesissn 1477-7525pubdate 2012volume 10issue 1fpage 43url http://www.hqlo.com/content/10/1/43xrefbib pubidlist pubid idtype doi 10.1186/1477-7525-10-43pmpid 22545870history rec date day 26month 9year 2011acc 3042012pub 2252012cpyrt 2012collab Bendixen et al.; licensee BioMed Central Ltd.note This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.kwdg kwd Duchenne muscular dystrophyICFParticipationQuality of lifeabs sec st AbstractBackgroundDuchenne muscular dystrophy (DMD) is characterized by muscle damage and progressive loss of muscle function in male children. DMD is one of the most devastating genetically linked neuromuscular diseases for which there is currently no cure. Most clinical studies for DMD utilize a standard protocol for measurement exploring pathophysiology, muscle strength and timed tasks. However, we propose that examining broader components of health as emphasized by the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY) may be of great value to children and their families, and important outcomes for future clinical trials.MethodsFifty boys with DMD and 25 unaffected age-matched boys completed two self-report measures: the Children’s Assessment of Participation and Enjoyment and the Pediatric Quality of Life Inventorysup TM 4.0. We investigated differences between the two groups with regard to participation in life activities and perceived quality of life (QoL). Additionally, we compared participation in activities and QoL in both cohorts of younger and older boys.ResultsParticipation in physical activities was significantly lower in boys with DMD than unaffected boys. Perceived QoL was markedly diminished in children with DMD relative to unaffected controls, except in the emotional domain. The amount of time boys engage in an activity, as well as participation in social activities, declined for our older boys with DMD but no changes were observed for our older unaffected boys. For both groups, QoL remained constant over time.ConclusionsThe ICF-CY provides a conceptual framework and specific terminology that facilitates investigation of the consequences of impairment in children and youth. Our study is one of the first to explore participation in a cohort of boys with DMD. It was not surprising that activities of choice for boys with DMD were less physical in nature than unaffected boys their age, but the consequences of less social engagement as the boys with DMD age is of great concern. Results from our study underscore the need to further evaluate activities that children elect to participate in, with special emphasis on facilitators and barriers to participation and how participation changes throughout the course of a disease.bdy BackgroundDuchenne muscular dystrophy (DMD), the most common form of muscular dystrophy, is a genetically-linked disease of male children which affects one in 3,300 boys abbrgrp abbr bid B1 1. The muscle damage and weakness which occurs with this disease leads to a progressive decline in the boy’s ability to perform everyday tasks, such as climbing stairs and walking short distances B2 2B3 3B4 4. Disruption to the lives of children with DMD and their families begins as early as age three when muscle weakness interferes with daily activities. As the weakness progresses, the boys often become confined to wheelchairs early in the second decade of life B5 5. End stage cardiac and respiratory complications lead to death which frequently occurs around the age of 20 B6 6B7 7B8 8. Overall, DMD leads to a loss of functional independence and deterioration in the quality of life for both the children and their families B9 9B10 10B11 11B12 12B13 13.It is imperative to develop techniques which can be used to follow the progression of this disease as well as the efficacy of any therapeutic interventions. Traditional measures used to follow DMD are typically clinical measures of skeletal muscle structure and function B14 14B15 15B16 16B17 17. These outcome measures include muscle strength, manual muscle testing, range of motion, forced vital capacity, anthropometric tests, timed functional tests and the 6 min walk. In addition, there are also invasive techniques, such as muscle biopsy, and noninvasive techniques, such as magnetic resonance imaging, which have been used to follow the structural and compositional changes that occur with the progression of DMD B18 18B19 19. Although these measures represent the current models on which clinical progression of the disease is based B20 20B21 21, such measurements may not fully capture the impact of the disease on real life activities. The medical community has long assumed that disability directly correlates with the measurements made in a clinical setting. However, it has been shown that measures of pathophysiology and motor function assessed in the clinic do not necessarily relate to or predict how patients deal with life situations B22 22B23 23B24 24. Clinical measures are often disconnected from the context and synergy of everyday life. Therefore, perhaps other nontraditional outcome measures would also be valuable in following the progression of DMD.One outcome measure which could be used to evaluate the ability of boys with DMD to manage real life situations is to determine their degree of it participation in various activities. The International Classification of Functioning, Disability, and Health-Children and Youth Version (ICF-CY) adopted by the World Health Organization (WHO) B25 25 (Figure figr fid F1 1) identifies participation as an important outcome of health. Participation is defined as direct engagement in a life situation including activities of personal care, mobility, social relationships, education, recreation and leisure, spirituality, and community life 25B26 26. It has been reported that children with physical disabilities engage in less varied activities than healthy children B27 27B28 28B29 29B30 30. To the best of our knowledge, participation levels among children with DMD and changes in the patterns of participation with age and disease progression have not been investigated. Therefore, there is a need to quantify participation in boys with DMD and the effect participation may have on their quality of life throughout the course of the disease.fig Figure 1caption International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY).text
b International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY).
graphic file 1477-7525-10-43-1 Quality of life (QoL) measures have often been used in the healthcare field to compare diseases, determine the effects of an illness B31 31, and measure the outcomes of treatments and clinical trials B32 32B33 33. It is possible that QoL measures can shed new insight into patient outcomes that traditional physical measures may not be able to assess 1133B34 34B35 35. It has been reported that children with chronic illnesses typically score below healthy children in QoL assessments, although patients with progressive diseases such as DMD have been excluded from most comparative studies B36 36B37 37. Surprisingly, there is little information on the QoL of children with DMD despite parents reporting quality of life issues as an important challenge for their children B38 38B39 39. The progressive decline in strength and loss of the ability to participate in activities with their peers can lead to social exclusion and isolation for these boys. These factors may have a significant impact on how boys with DMD perceive their quality of life.The objectives of this investigation were 1) to compare boys with DMD with an unaffected age-matched population of boys with regard to participation in real life activities and perceived quality of life, 2) to determine the differences in participation in activities and perceived quality of life in younger and older boys with DMD and unaffected boys to explore the effects of disease progression, and 3) to determine if there is a relationship between participation in activities and perceived quality of life in younger and older boys with DMD and unaffected boys. This was accomplished by using two self-report outcome measures, the Children’s Assessment of Participation and Enjoyment (CAPE) and the Pediatric Quality of Life InventoryTM 4.0 (PedsQL).MethodsIn our study we collected data from a cohort of boys participating in a larger natural history study exploring biomarkers of disease progression in Duchenne muscular dystrophy. Our study investigated self-report of participation levels and QoL in boys with DMD compared to unaffected age-matched boys. Fifty boys with DMD (validated through medical report using molecular genetic testing and/or immunohistochemical staining from muscle biopsy) and their parent(s) volunteered to enroll in this study. Twenty-five unaffected age-matched boys were recruited from the general population for comparisons in participation and QoL. Unaffected boys were relatively sedentary, in that they did not participate in sport specific training more than 2 times per week. All boys and their parents participated in person at our site. The boys ranged in age from 5 to 15 years. Three boys with DMD who were nonambulatory were included in this study; all others were ambulatory at the time of testing. The study was approved by the University of Florida Institutional Review Board (IRB 129-2008). Written, informed consent was obtained from the parent(s), and written assent was obtained from each participant. Following informed consent, the boys completed two paper/pencil self-report assessments which focused on participation in physical, recreational and social activities and perceived quality of life. Assessments of participation were completed with the assistance of their parent(s).InstrumentsParticipation was measured by the Children’s Assessment of Participation and Enjoyment (CAPE)B40 40. The CAPE is designed to examine how children and youth participate in everyday activities. Scores on the CAPE are divided into five dimensions: 1) ul Diversity, the number of activities performed overall; 2) Intensity, the frequency of performing the activity; 3) With Whom the activity is performed; 4) Where the activity is performed; and 5) how much Enjoyment the child gets from the activity. Additionally, activities are divided into the following domains: physical, recreational, social, skill-based, and self-improvement. Three activity domains of the CAPE were used in our calculations (physical, recreational and social activities). Physical activities included such items as playing team sports, bicycling, and actively using playground equipment. Recreational activities included reading, playing cards or playing video/computer games. Social activities included visiting friends, going to the movies, and cooking. Reliability and validity of the CAPE were established using data from a longitudinal study involving 427 children with physical disabilities 27. Although validation studies with the CAPE did not include children with progressive diseases, such as DMD, other diagnoses which result in muscle weakness and motor difficulties were included (i.e., cerebral palsy, amputation, muscular disorders, neuropathy, orthopaedic conditions, vascular brain disorders). In addition, the CAPE was designed to be a direct measure of participation as reflected by the WHO’s ICF model 27. The CAPE documents what a child does in their everyday life, not the child’s competence or the degree of support required to participate in the activity 28. Therefore it was felt the CAPE measure would adequately capture the boys with DMD involvement in life situations.Quality of Life (QoL) was assessed through the Pediatric Quality of Life InventoryTM 4.0 (PedsQL), which is designed to measure the core dimensions of health as delineated by the WHO (physical, emotional, social), as well as school functioning, and has been determined to be a thorough and reliable measure of QoL in children 3637B41 41. Generic quality of life instruments have frequently been used as patient reported outcome measures, and their use encouraged to explore the clinical meaningfulness of a change in more traditional clinical measures of body systems and overall function 2633. Generic QoL measurements provide valuable information for comparing populations, but may not be sensitive enough to detect change necessary for a treatment based clinical trial B42 42. The PedsQLTM 4.0 has previously been used to evaluate patient-perceived well being in boys with DMD and unaffected controls B43 43 and to investigate agreement between boys with DMD and their parents when reporting quality of life 13B44 44. The data for the Generic Core Scales were derived from the PedsQLTM 4.0 field test 37. Generic Core Scales included children who are healthy, acutely ill, and chronically ill.Statistical analysisAll statistical analyses were performed using statistical software PASW version 18.0 for Windows (PASW Inc., Chicago, IL). The Mann–Whitney U-test was used for group comparisons and the Spearman’s rank correlation coefficient test was used for non-parametric analysis of correlations. A p-value of less than or equal to 0.05 was considered statistically significant. In our aim of exploring the differences in participation in life activities and perceived QoL between younger and older unaffected boys and boys with DMD, a p-value of less than or equal to 0.01 was considered statistically significant due to the multiple number of analyses performed.ResultsCharacteristics of boys with DMD and unaffected age-matched boysA comparison of the characteristics of the boys with Duchenne muscular dystrophy (DMD) and the unaffected age-matched boys used in this study is shown in Table tblr tid T1 1. The ages and weights of the boys in both groups were comparable. However, boys with DMD were shorter in height and had a higher body mass index (BMI) than unaffected boys. One possible reason for the decrease in height and higher BMI may be the fact that all boys in the DMD group were taking steroids. It is known that administration of steroids may result in weight gain and short stature B45 45. A comparison of the ability to participate in life activities and their perceived QoL was made between these two groups, and the results are presented below.table Table 1Characteristics of DMD and unaffected age-matched subjectstgroup align left cols 3 colspec colname c1 colnum 1 colwidth 35* c2 2 c3 30* thead valign top row rowsep entry DMD (n = 50)Unaffected (n = 25)tfoot p ≤ .05; **p ≤ .01.tbody Age8.9 (2.4)8.4 (2.1)Weight (kg)32.3 (10.5)31.1 (10.2)Height (m)122.6 (12.5)142.5 (11.3)**BMI (kg/m2)19.5 (3.4)16.7 (3.4)*Participation and QoL in boys with DMD Vs unaffected boysParticipation in life activities for each group was assessed using the Children’s Assessment of Participation and Enjoyment (CAPE), a self-report outcome measure. The results were divided into four categories (Figure F2 2). Intensity is a measure of the frequency of participation in chosen activities varying from no participation (score 0) to once in the last 4 months (score 1) to daily (score 7). The total number of activities in which an individual participates in (Diversity) and intensity scores are used to compute scores for the three different types of activities: physical, recreational, and social. The range of activity scores is from 0 (lowest participation) to 7 (highest participation). The results showed lower participation levels in physical activities in DMD (p < .001), but no significant differences between boys with DMD and unaffected boys in diversity or any of the other categories (intensity, recreational or social activities).Figure 2Baseline CAPE Responses by DMD (n = 50) and Unaffected Age-Matched Subjects (n = 25).
Baseline CAPE Responses by DMD (n = 50) and Unaffected Age-Matched Subjects (n = 25). CAPE, Children’s Assessment of Participation and Enjoyment collection instrument. DMD, Duchenne muscular dystrophy; Range of scores (Intensity 0–7; Physical Activities 0–7; Recreational Activities 0–7; Social Activities 0–7). Data are presented as means ± standard deviations. ***p <0. 001.
1477-7525-10-43-2 The perceived QoL for each group was assessed using the Pediatric Quality of Life InventoryTM 4.0 ™ (PedsQL), also a self-report outcome measure. These responses were divided into four subscales: physical, emotional, social, and school-related. In addition, a total QoL composite score was also included (Figure F3 3). The range of scores is from zero (lowest QoL) to 100 (highest QoL). There were lower scores for boys with DMD than the unaffected group in physical, social, school-related, and total composite quality of life responses. There were no significant differences between groups in the responses related to emotional factors. These results demonstrate that, in general, the perceived QoL is diminished in boys with DMD.Figure 3Baseline PedsQLTM Responses by DMD (n = 50) and Unaffected Age-Matched Subjects (n = 25).
Baseline PedsQL Responses by DMD (n = 50) and Unaffected Age-Matched Subjects (n = 25) . DMD, Duchenne muscular dystrophy; PedsQLTM, Pediatric Quality of Life collection instrument; Range of scores 0–100. Data are presented as means ± standard deviations. *p <0.05; **p < 0.01; ***p < 0.001.
1477-7525-10-43-3 Participation and QoL in younger and older boysTo assess the effects of disease progression, the boys with DMD and unaffected boys were divided into two age groups, i.e., less than 10 years and 10 years or older. The age of 10 years was selected because of the disease progression and the muscle and functional changes that reportedly occur for boys with DMD around this age, including the ability to rise from the floor, walk up stairs or ambulate 51719. All demographics for these two age groups (age, height, weight, BMI) were statistically significantly different at p < .001. For boys with DMD, there were significant differences between the two age groups in CAPE scores of direct participation in social activities (p ≤ 0.01) and a trend toward significance in overall frequency of participation in all activities (p ≤ 0.05), but no differences in diversity of activities or participation in physical or recreational activities. No differences were observed between these two DMD age groups in self-report of QoL in any of the subscale scores or the total composite score of the PedsQLTM (Table T2 2). These results demonstrate that overall, older boys with DMD participate in a variety of activities, but less often than their younger peers. More importantly, engagement in social activities declined significantly for our older boys with DMD. Interestingly, perceived quality of life did not vary between the two DMD age groups. For our unaffected group, no significant differences were found between the two age groups in any PedsQL TM subscale scores or total composite score (Table 2).Table 2Baseline CAPE and PedsQLTM responses by DMD and unaffected based on age groups: differences within and between groups7 15* 14* c4 4 c5 5 c6 6 c7 Instrumentsnameend namest DMD (n = 50)Unaffected (n = 25)P value Between Groups<10 yearsP valueBetween Groups ≥ 10 years<10 years (n = 27)≥ 10 years (n = 23)<10 years (n = 13)≥ 10 years (n = 12)DMD, Duchenne muscular dystrophy; CAPE, Children’s Assessment of Participation and Enjoyment collection instrument; CAPE, Range of scores (Diversity 0–55; Intensity 0–7; Physical Activities 0–7; Recreational Activities 0–7; Social Activities 0–7); PedsQL, Pediatric Quality of Life collection instrument; PedsQL, Range of scores 0–100. Data are presented as means ± standard deviations. *p < .05; **p < .01.CAPE Diversity30.1 (5.2)27.6 (5.4)33.3 (7.1)30.1 (4.2)0.050.19CAPE Intensity2.7 (0.6)2.4 (0.5)*3.2 (0.8)2.6 (0.5)0.180.68CAPE Physical1.4 (0.7)1.3 (1.1)2.9 (0.9)2.5 (0.9)0.000.01CAPE Recreational4.9 (1.0)4.6 (1.1)5.2 (0.7)4.8 (0.7)0.380.42CAPE Social3.4 (0.9)2.4 (0.8)**3.1 (0.7)3.0 (0.9)0.850.02PedsQL Physical68.1 (16.7)61.6 (21.2)87.8 (11.5)85.3 (12.5)0.000.00PedsQL Emotional63.2 (17.6)71.8 (19.8)73.1 (18.8)73.6 (19.1)0.130.83PedsQL Social68.5 (22.9)65.9 (23.5)79.9 (21.3)86.4 (17.9)0.140.03PedsQL School64.5 (20.7)67.7 (18.0)78.9 (13.9)81.4 (13.7)0.180.05PedsQL Total Composite66.2 (11.4)66.7 (16.9)82.7 (13.1)81.6 (12.7)0.000.02Differences between the younger boys with DMD and the younger unaffected boys were observed in the CAPE area of physical participation, as well as the PedsQLTM physical subscale and total composite score (all significant at p ≤ 0.000). For our older cohort (≥10 years), boys with DMD scored significantly lower in the physical and social domains of the CAPE, as well as the PedsQLTM physical and social subscales and the total composite score (Table 2).Relationship between participation and QoLAs the results above demonstrate, participation in activities that were social in nature declined for the older cohort of boys with DMD; self-report of QoL did not differ between the two DMD or unaffected age groups. Correlational analyses showed no significant relationship between overall participation and perceived QoL in either age group of boys with DMD or unaffected boys.DiscussionIn this study we compared participation in life activities and perceived QoL between boys with DMD and an age-matched population of unaffected boys. The results showed that participation in physical activities was significantly lower in boys with DMD than unaffected controls, although other participation measures were much the same as healthy boys. Furthermore, perceived QoL was markedly diminished in children with DMD relative to unaffected controls. Another objective of this study was to compare younger boys to older boys in both the DMD and unaffected cohorts to explore both within group and between group differences in participation and QoL. For within group differences, we found that the amount of time boys with DMD engage in an activity (frequency), as well as participation in social activities, declined for our older cohort but there was no decline in participation observed for our older unaffected boys. No differences in perceived QoL were observed between the younger and older boys with DMD or the unaffected boys. Significant between age group differences were observed among the boys with DMD and the unaffected controls. Comparisons between our younger boys with DMD and our younger unaffected boys showed lower scores in diversity of activities they participate in, as well as participation in physical activities. Quality of life scores were lower in the physical subscale as well as the overall total composite score. For our older boys with DMD, lower scores were reported in both physical and social participation, as well as quality of life subscales of physical, social and total composite scores compared to our older unaffected boys. No differences were observed in the PedsQLTM subscales of emotional or school related QoL for our older boys. Finally, no correlations were observed between reports of participation and QoL in these two groups.Our study is one of the first to explore self-report of participation in activities in a population of boys with DMD. The results demonstrated that, overall, the boys with DMD chose diverse activities in which to participate and that they were involved in their chosen activities as frequently as healthy boys. However, the activities of choice for boys with DMD were less physical in nature than unaffected boys their age. It certainly comes as no surprise that children with muscular weakness are less likely to participate in physical activities, especially as they age B46 46B47 47. Interestingly, physical activity for healthy boys has been reported to decline during later childhood or adolescence stages B48 48B49 49, although we did not observe a decline in our unaffected group of boys. In contrast, this age-related decline in physical activities for unaffected boys does not appear to be due to the bodily demands of the activity 49B50 50. Moreover, physical activity participation is typically high for younger unaffected boys 50, but was significantly lower in our younger boys with DMD.In boys with DMD, participation in social activities, such as visiting friends, going to parties or going to the movies was significantly lower after the age of 10 years. This is often the age when boys with DMD experience a decrease in motor abilities, such as ambulation 546 and may, therefore, have less opportunity for community-based social engagement. It’s important to note the connection between physical abilities and social engagement. Poor motor skills have been associated with peer relationship difficulties, lower peer regard and greater likelihood of suffering from withdrawal B51 51. Actively engaging in physical activities, such as team sports or playing with others on the playground, helps children form peer relationships and experience a sense of self-worth and belonging to a group 304051B52 52. Unfortunately, little is known about the social engagement of children with DMD. Although parents more often report prolonging ambulation as the most important factor in dealing with DMD 39B53 53, the resulting emotional challenges of DMD and the increasing social needs of boys as they age is also of great concern 39B54 54.Our study also used self-report measures to determine the perceived QoL of the boys with DMD relative to unaffected controls. The boys with DMD reported lower physical, social and school-related scores, resulting in significantly lower total composite QoL scores. However, there was no effect of the disease in the emotional area of QoL, even as the boys aged. The differences in these responses may be due to the types of questions used in the PedsQLTM assessment. The questions addressed in the physical, social, and school-related areas are based on difficulties in actual performance, such as physical activities, making friends, or missing school due to medical/physician appointments. On the other hand, the emotional subscale of the PedsQLTM consists of questions about feelings of sadness, anger, and fear. These may be emotions that are evident in most children to some degree and may not necessarily be exaggerated by the disease. It is interesting to note that although QoL scores for boys with DMD were significantly lower than for unaffected boys, these scores did not notably decrease within the cohort of children with DMD when the disease has typically progressed. Other researchers have also reported no changes in QoL related to disease progression 111243B55 55. In a longitudinal study, Simon and colleagues (2010) used the Life Satisfaction Index for Adolescents, which they determined to be a more effective instrument for boys with DMD based on its limited focus on physical abilities. No comparisons were made with unaffected boys, but the cohort of 95 boys with DMD did not show a significant decrease and no loss of QoL was observed among the boys most affected by the progression of the disease 55. Abresch et al. B56 56B57 57 determined that physical functioning and level of disability alone did not alter overall QoL, a finding that was also reported by Kohler et al. 43 using the Short-Form 36 of the medical outcome questionnaire. Finally, based on PedsQLTM scores established and validated in a variety of patient populations 37B58 58, the overall scores for our cohort of boys with DMD were lower than scores from children with other major chronic health issues.In our study, we did not find a relationship between CAPE participation scores and PedsQLTM quality of life scores for unaffected boys or boys with DMD, although relationships between QoL and specific clinical measures that are typically assessed in boys with DMD have been observed. Bray et al. 13 found relationships between age, steroid use, physical functioning and QoL in DMD. McDonald et al. 44 utilized parent-proxy report and found direct relationships between the physical domains of QoL, age, and such clinical assessments as supine to stand, walk/run 10 meters and walk up 4 stairs. Findings from other studies in DMD support the thought that meaningful and developmentally important life activities, such as playing with and actively engaging with friends, may be related to QoL 11B59 59. It is difficult to explain these varying results and why we did not find a correlation between participation and QoL. Although our sample size was small, it would also appear that QoL is complex and more global in nature than the straightforward and explicit report of actual participation. As Colver theorized, QoL cannot be measured directly, but only captured through a variety of questions that seek to place value on a particular variable B60 60. Therefore, QoL is a concept and is subjective 55, while participation is a real life experience and is objective B61 61B62 62B63 63. Finally, our results may differ from some studies because we chose to use child report in lieu of parent proxy report to obtain a full understanding of the children’s perception of their QoL. Literature in this area shows that parents and children often differ in their agreement of the child’s QoL 1344B64 64, but the larger issue appears to be whether a child is capable of self-report B65 65B66 66. We took the stance, as others have, that children can provide valuable information about their health and that quality of life is subjective and therefore should be a person’s individual view 33616566.LimitationsWe acknowledge there are a few limitations to our study. Although our population of boys with DMD is rare, our sample size may be considered relatively small, especially when broken into age groups. Moreover, as this was not a longitudinal study, comparing different age groups may not be giving us information about changes as the disease progresses. Lastly, although the PedsQLTM is a thoroughly developed generic measure that is brief, easy to understand, and captures information relevant to both children with a disease/illness and unaffected children, we acknowledge that the PedsQLTM domains are limited, are not designed to assess a full range of functioning and are not specific to children with a neuromuscular disorder.ConclusionsAlthough a progressive disease, such as DMD, influences the physical ability to participate in many activities, it’s important to acknowledge that restrictions in participation should not inevitably arise from this or any childhood disease. Optimum management of DMD requires a multidisciplinary approach that focuses on anticipatory and preventive measures as well as active interventions to address the primary and secondary complications resulting from the disorder 6. Such a multidisciplinary approach would benefit from using a framework to conceptualize the process of living with a progressive disease. The ICF-CY 25 provides a conceptual framework and specific terminology that facilitates investigation of the consequences of chronic illness and impairment in children and youth. The ICF model provides areas of intervention that can enhance the participation of children whose functional well-being is at risk. Interventions that focus on multiple aspects of the child and address participation afford children the opportunity to continue to engage in age and developmentally appropriate activities, and ultimately may serve to promote overall health 6162. Results from our study underscore the need to further evaluate activities that children elect to participate in to obtain an accurate account of a child’s level of participation and how participation changes throughout the course of a disease. Additionally, exploring how participation may relate to specific clinical tests may give us a better understanding of areas of intervention.Competing interestsThe authors declare that they have no competing interestsAuthors’ contributionsRMB conceived and designed the study, acquired the data, analyzed and interpreted the data and drafted and revised the manuscript. CS recruited the subjects, scheduled times for the evaluations, and helped to draft and revise the manuscript. DJL participated in the design of the study and helped to draft and revise the manuscript. KV is the principal investigator of the larger study from which this pilot data was collected; KV participated in the design of the study and was involved in the drafting of the manuscript and revising for critically important intellectual content. All authors participated sufficiently in the work to take public responsibility for appropriate portions of the content. All authors read and approved the final manuscript.bm ack AcknowledgementsThe authors would like to like to thank the children and families who gave their time to participate in this study. We would also like to acknowledge Dr. Phil Miles for his efforts in drafting and revising the manuscript. Dr. Bendixen is currently funded through an NIH – NICHD K01mentored career development grant (5K01HD064778) and is in Phase II of an NIH K12 institutional grant (K12 HD055929). Additional funding for recruitment and participant support was provided through Parent Project Muscular Dystrophy and the Muscular Dystrophy Association (PI, K. Vandenborne) and a grant through a Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (PI, L. Sweeney).refgrp Pathophysiology of Duchenne muscular dystrophyDeconinckNDanBPediatr Neurol20073611lpage 710.1016/j.pediatrneurol.2006.09.016link fulltext 17162189Dystrophin: The protein product of the Duchenne muscular dystrophy locusHoffmanEPBrownRHKunkelLMCell19875191992810.1016/0092-8674(87)90579-43319190Duchenne muscular dystrophySussmanMJ Ame Acad Orthop Surg2002102138151The role of free radicals in the pathophysiology of muscular dystrophyTidballJGWehling-HenricksMJ Appl Physiol200710241677168617095633EmeryAMuntoniFDuchenne Muscular Dystrophypublisher Oxford University Press, Oxfordedition 32003Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary careBushbyKFinkelRBirnkrantDJCaseLEClemensPRCripeLKaulAKinnettKMcDonaldCPandyaSPoyskyJShapiroFTomezskoJConstantinCLancet Neurol20109217718910.1016/S1474-4422(09)70272-819945914DystrophinopathiesDarrasBTMenacheCCKunkelLMNeuromuscular Disorders of Infancy, Childhood and Adolescence-A Clinician’s ApproachButterworth Heinemann, Amsterdameditor Jones HR, DeVivo DC, Darras BT2003649700DystrophinopathiesHoffmanEPDisorders of MuscleCambridge University Press, CambridgeKarpati G, Hilton-Jones D, Griggs RC2001385482The psychosocial impact of a progressive physical handicap and terminal illness (Duchenne muscular dystrophy) on adolescents and their familiesWitteRABr J Med Psychol19855817918710.1111/j.2044-8341.1985.tb02632.x4016022The impact of Duchenne muscular dystrophy on familiesGagliardiBAOrthop Nurs1991105414910.1097/00006416-199109000-000091923575Living with muscular dystrophy: health related quality of life consequences for children and adultsGrootenhuisMAde BooneJvan der KooiAJHealth and Quality of Life Outcomes200753118pmcid 176936017201920Quality of life in Duchenne muscular dystrophy: The subjective impact on children and parentsBaiardiniIMinettiCBonifacinoSPorcuAKlersyCPetraliaPBalestracciSTarchinoFParodiSCanonicaGWBraidoFJ Child Neurol201126670771310.1177/088307381038904321482750Thank, Ryan MM, North KN, Everett A: Health-related quality of life in boys with Duchenne muscular dystrophy: Agreement between parents and their sonsBrayPJ Child Neurol201025101188119410.1177/088307380935762420179004Clinical trials in Duchenne dystrophy. I. The design of the protocolBrookeMHGriggsRCMendellJRFenichelGMShumateJBPellegrinoRJMuscle Nerve1981418619710.1002/mus.8800403047017401Quantification of muscle function in children: a prospective study in Duchenne muscular dystrophyScottOMHydeSAGoddardCDubowitzVMuscle Nerve1982529130110.1002/mus.8800504057099196The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophyMcDonaldCMHenricsonEKHanJJAbreschRTNicoriciAElfringGLAtkinsonLRehaAHirawatSMillerLLMuscle Nerve201041450051010.1002/mus.2154419941337Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patientsBeenakkerEAMauritsNMFockJMBrouwerOFvan der HoevenJHEur J Paediatr Neurol2005938739310.1016/j.ejpn.2005.06.00416102988New therapies for Duchenne muscular dystrophy: Challenges, prospects and clinical trialsCossuGSampaolesiMTrends Mol Med2007131252052610.1016/j.molmed.2007.10.00317983835ChamberlainJRandoTDuchenne Muscular Dystrophy: Advances in TherapeuticsTaylor & Francis Group, New York2006Profiles of neuromuscular diseases. Duchenne muscular dystrophyMcDonaldCMAbreschRTCarterGTFowlerWMJohnsonERKilmerDDSigfordBJAm J Phys Med Rehabil1995745 SupplS70S927576424Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment toolScottEMawsonSJDev Med Child Neurol20064854054410.1017/S001216220600113716700951Diagnosis to function: classification for children and youthsLollarDJSimeonssonRJJ Dev Behav Pediatr200526432333010.1097/00004703-200508000-0001216100508Association of environmental factors with levels of home and community participation in an adult rehabilitation cohortKeysorJJJetteAMCosterWBettgerJPHaleySMArch Phys Med Rehabil200687121566157510.1016/j.apmr.2006.08.34717141635Beyond function: predicting participation in a rehabilitation cohortJetteAMKeysorJCosterWNiPHaleySArch Phys Med Rehabil200586112087209410.1016/j.apmr.2005.08.00116271553cnm World Health Organization (WHO)International Classification of Functioning, Disability and Health: Children & Youth VersionGeneva, Switzerland200722563683World Health Organization (WHO)International Classification of Functioning, Disability and HealthGeneva, Switzerland2001Patterns of participation in recreational and leisure activities among children with complex physical disabilitiesLawMKingGKingSKertoyMHurleyPRosenbaumPYoungNHannaSDev Med Child Neurol20064833734210.1017/S001216220600074016608540Measuring children’s participation in recreation and leisure activities: Construct validation of the CAPE and PACKingGLawMKingSHurleyPHannaSKertoyPRosenbaumPChild Care Health Dev20063312839Social functioning in children with a chronic illnessMeijerSASinnemaGBijstraJOMellenberghGJWoltersWHJ Child Psychol Psychiatry200041330931710.1111/1469-7610.0061510784078Impact of impairment on activity patterns of childrenBrownMGordonWArch Phys Med Rehabil1987688288322962558HollingsworthHMorganKCuthbertJGreyDMeasure of quality of participation in life situations for people with mobility limitationsICF Sessions at APHA Annual Meeting, San Francisco2003The role of corticosteroids in muscular dystrophy: A critical appraisalAngeliniCMuscle Nerve20073642443510.1002/mus.2081217541998The measurement of quality of life in children: past and future perspectivesEiserCMorseRJ Dev Behav Pediatr20012224825610.1097/00004703-200108000-0000711530898Pain and activity limitations in children with Duchenne or Becker muscular dystrophyZebrackiKDrotarDDev Med Child Neurol200850754655210.1111/j.1469-8749.2008.03005.x18611207Activities of daily living and quality of life in persons with muscular dystrophyNatterlundBAhlstromGJ Rehabil Med20013320621110.1080/16501970175041959011585151Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core ScalesVarniJWLimbersCABurwinkleTMHealth Qual Life Outcomes200754310.1186/1477-7525-5-43196478617634123PedsQL™ 4.0: Reliability and validity of the pediatric quality of life inventory™ version 4.0 generic core scales in healthy and patient populationsVarniJWSeidMKurtinPSMed Care200139880081210.1097/00005650-200108000-0000611468499Parents's perspectives on coping with Duchene muscular dystrophyWebbCChild Care Health Dev20053138539610.1111/j.1365-2214.2005.00518.x15948875Duchenne muscular dystrophy—Parental perceptionsBothwellJEDooleyJMGordonKEMacAuleyACamfieldPRMacSweenJClin Pediatr20024110510910.1177/000992280204100206KingGLawMKingSHurleyPRosenbaumPHannaSKertoyMYoungNChildren’s Assessment of Participation and Enjoyment & Preferences for Activities of ChildrenHarcourt Assessment, Inc, San Antonio, TX200422606702A review of measures of quality of life for children with chronic illnessEiserCMorseRArch Dis Child20018420521110.1136/adc.84.3.205171869911207164The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic reviewClarkS-AEiserCHealth Qual Life Outcomes20042667010.1186/1477-7525-2-6653478515555077Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophyKohlerMClarenbachFBoniLBrackTRussiEBlochKAm J Respir Crit Care Med20051721032103610.1164/rccm.200503-322OC15961695Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophyMcDonaldCMMcDonaldDABagleyAThomasSSBuckonCEHenricsonENicoriciASussmanMDJ Child Neurol20102591130114410.1177/088307381037150920558672Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for managementMoxleyRTPandyaSCiafaloniEFoxDJCampbellKJ Child Neurol20102591116112910.1177/088307381037100420581335Physical activity, health impairments, and disability in neuromuscular diseaseMcDonaldCMAm J Phy Med Rehabil200281Suppl 11108120Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophyMcDonaldCMWidmanLMWalshDDWalshSAAbreschRTArch Phys Med Rehabil20058680280810.1016/j.apmr.2004.10.01215827935Trends by age in youth physical activity: Youth media campaign longitudinal surveyWallMICarlsonSASteinADLeeSMFultonJEMed Sci Sports Exerc20114321402147Epub ahead of print10.1249/MSS.0b013e31821f561a21502886Bo Andersen L, Wedderkopp N, Harro M, Klasson-Heggebǿ L, Sardinha LB, Cooper AR, Ekelund U: Physical activity levels and patterns of 9- and 15-year-old European childrenRiddochCHMed Sci Sports Exerc200436869210.1249/01.MSS.0000106174.43932.9214707773Physical activity in the United States measured by accelerometerTroianoRPBerriganDDoddKWMasseLCTilertTMcDowellMMed Sci Sports Exerc20084018118818091006Lum Mow M, Toshack T, Zheng Y: The relationship between motor performance and peer relations in 9- to 12-year-old childrenLiveseyDChild Care Health Dev201037458158821143269Predicting life satisfaction among adults with physical disabilitiesKinneyVBCoyleCPArch Phys Med Rehabil1992738638691387523Factors relating to carer burden for families of persons with muscular dystrophyBoyerFDrameMMorroneINovellaJ-LJ Rehabil Med20063830931510.1080/1650197060073157816931461Social behavior problems in boys with Duchenne musuclar dystrophyHintonVNereoNFeeRCyrulnikSDev Behav Pediatr200727470476Duchenne muscular dystrophy: Quality of life among 95 patients evaluated using the Life Satisfaction Index for AdolescentsSimonVAResendeMBSimonMAZanoteliEReedUCArq Neuropsiquiatr2011691192210.1590/S0004-282X201100010000521359417New clinical end points in rehabilitation medicine: tools for measuring quality of lifeAbreschRTCarterGTHanJJMcDonaldCMAm J Hosp Palliat Care200926648349210.1177/104990910935265619923631Quality of life. Issues for persons with neuromuscular diseasesAbreschRTSeydenNKWineingerMAPhys Med Rehabil Clin N Am1998912332489894142The linkage between pediatric quality of life and health conditions: Establishing clinically meaningful cutoff scores for the PedsQLHuangI-CThompsonLAChiY-YKnappCARevickiDASeidMShenkmanEAValue in Health200912577378110.1111/j.1524-4733.2008.00487.x19508660El-Jaroudi: Measures of social outcomes in disability researchDijkersMWhiteneckGArch Phys Med Rehabil200081Suppl 26380Quality of life and participationColverADev Med & Child Neuro20095165665910.1111/j.1469-8749.2009.03321.x315411121593732Participation in childhoodForsythRJarvisSChild Care Health Dev20022827727910.1046/j.1365-2214.2002.00272.x12190818Successful participation: the lived experience among children with disabilitiesHeahTCaseTMcGuireBLawMCan J Occup Ther200774384710.2182/cjot.06.1017319321The PedsQL™. Measurement model for the pediatric quality of life inventoryVarniJWMedical Care199937212613910.1097/00005650-199902000-0000310024117Agreement between adolescent self-report and parent reports of health and wellbeing: results of an epidemiological studyWatersEStewart-BrownSFitzpatrickRChild Care Health Dev20032950150910.1046/j.1365-2214.2003.00370.x14616908Evidence that school-age children can self-report on their healthRileyAAmbul Pediatr2004437137610.1367/A03-178R.115264962Elementary school-aged children’s reports of their health: a cognitive interviewing studyRebokGRileyAWForrestCStarfieldBGreenBRobertsonJTamborEQual Life Res200110597010.1023/A:101669341716611508476